Gold nanoparticles–conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt–mediated pathway in breast cancer cell lines (MCF‐7 and MDA‐MB‐231)
Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of g...
Gespeichert in:
| Veröffentlicht in: | Cell biochemistry and function Jg. 35; H. 4; S. 217 - 231 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Wiley Subscription Services, Inc
01.06.2017
|
| Schlagworte: | |
| ISSN: | 0263-6484, 1099-0844, 1099-0844 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of gold nanoparticles–conjugated quercetin (AuNPs‐Qu‐5) in MCF‐7 and MDA‐MB‐231 breast cancer cell lines. Borohydride reduced AuNPs were synthesized and conjugated with quercetin to yield AuNPs‐Qu‐5. Both were thoroughly characterized by several physicochemical techniques, and their cytotoxic effects were assessed by MTT assay. Apoptotic studies such as DAPI, AO/EtBr dual staining, and annexin V‐FITC staining were performed. AuNPs and AuNPs‐Qu‐5 were spherical with crystalline nature, and the size of particles range from 3.0 to 4.5 nm. AuNPs‐Qu‐5 exhibited lower IC50 value compared to free Qu. There was a considerable increase in apoptotic population with increased nuclear condensation seen upon treatment with AuNPs‐Qu‐5. To delineate the molecular mechanism behind its apoptotic role, we analysed the proteins involved in apoptosis and epidermal growth factor receptor (EGFR)–mediated PI3K/Akt/GSK‐3β signalling by immunoblotting and immunocytochemistry. The pro‐apoptotic proteins (Bax, Caspase‐3) were found to be up regulated and anti‐apoptotic protein (Bcl‐2) was down regulated on treatment with AuNPs‐Qu‐5. Additionally, AuNPs‐Qu‐5 treatment inhibited the EGFR and its downstream signalling molecules PI3K/Akt/mTOR/GSK‐3β. In conclusion, administration of AuNPs‐Qu‐5 in breast cancer cell lines curtails cell proliferation through induction of apoptosis and also suppresses EGFR signalling. AuNPs‐Qu‐5 is more potent than free quercetin in causing cancer cell death, and hence, this could be a potential drug delivery system in breast cancer therapy. |
|---|---|
| AbstractList | Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of gold nanoparticles-conjugated quercetin (AuNPs-Qu-5) in MCF-7 and MDA-MB-231 breast cancer cell lines. Borohydride reduced AuNPs were synthesized and conjugated with quercetin to yield AuNPs-Qu-5. Both were thoroughly characterized by several physicochemical techniques, and their cytotoxic effects were assessed by MTT assay. Apoptotic studies such as DAPI, AO/EtBr dual staining, and annexin V-FITC staining were performed. AuNPs and AuNPs-Qu-5 were spherical with crystalline nature, and the size of particles range from 3.0 to 4.5 nm. AuNPs-Qu-5 exhibited lower IC
value compared to free Qu. There was a considerable increase in apoptotic population with increased nuclear condensation seen upon treatment with AuNPs-Qu-5. To delineate the molecular mechanism behind its apoptotic role, we analysed the proteins involved in apoptosis and epidermal growth factor receptor (EGFR)-mediated PI3K/Akt/GSK-3β signalling by immunoblotting and immunocytochemistry. The pro-apoptotic proteins (Bax, Caspase-3) were found to be up regulated and anti-apoptotic protein (Bcl-2) was down regulated on treatment with AuNPs-Qu-5. Additionally, AuNPs-Qu-5 treatment inhibited the EGFR and its downstream signalling molecules PI3K/Akt/mTOR/GSK-3β. In conclusion, administration of AuNPs-Qu-5 in breast cancer cell lines curtails cell proliferation through induction of apoptosis and also suppresses EGFR signalling. AuNPs-Qu-5 is more potent than free quercetin in causing cancer cell death, and hence, this could be a potential drug delivery system in breast cancer therapy. Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of gold nanoparticles-conjugated quercetin (AuNPs-Qu-5) in MCF-7 and MDA-MB-231 breast cancer cell lines. Borohydride reduced AuNPs were synthesized and conjugated with quercetin to yield AuNPs-Qu-5. Both were thoroughly characterized by several physicochemical techniques, and their cytotoxic effects were assessed by MTT assay. Apoptotic studies such as DAPI, AO/EtBr dual staining, and annexin V-FITC staining were performed. AuNPs and AuNPs-Qu-5 were spherical with crystalline nature, and the size of particles range from 3.0 to 4.5 nm. AuNPs-Qu-5 exhibited lower IC50 value compared to free Qu. There was a considerable increase in apoptotic population with increased nuclear condensation seen upon treatment with AuNPs-Qu-5. To delineate the molecular mechanism behind its apoptotic role, we analysed the proteins involved in apoptosis and epidermal growth factor receptor (EGFR)-mediated PI3K/Akt/GSK-3[beta] signalling by immunoblotting and immunocytochemistry. The pro-apoptotic proteins (Bax, Caspase-3) were found to be up regulated and anti-apoptotic protein (Bcl-2) was down regulated on treatment with AuNPs-Qu-5. Additionally, AuNPs-Qu-5 treatment inhibited the EGFR and its downstream signalling molecules PI3K/Akt/mTOR/GSK-3[beta]. In conclusion, administration of AuNPs-Qu-5 in breast cancer cell lines curtails cell proliferation through induction of apoptosis and also suppresses EGFR signalling. AuNPs-Qu-5 is more potent than free quercetin in causing cancer cell death, and hence, this could be a potential drug delivery system in breast cancer therapy. Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of gold nanoparticles-conjugated quercetin (AuNPs-Qu-5) in MCF-7 and MDA-MB-231 breast cancer cell lines. Borohydride reduced AuNPs were synthesized and conjugated with quercetin to yield AuNPs-Qu-5. Both were thoroughly characterized by several physicochemical techniques, and their cytotoxic effects were assessed by MTT assay. Apoptotic studies such as DAPI, AO/EtBr dual staining, and annexin V-FITC staining were performed. AuNPs and AuNPs-Qu-5 were spherical with crystalline nature, and the size of particles range from 3.0 to 4.5 nm. AuNPs-Qu-5 exhibited lower IC50 value compared to free Qu. There was a considerable increase in apoptotic population with increased nuclear condensation seen upon treatment with AuNPs-Qu-5. To delineate the molecular mechanism behind its apoptotic role, we analysed the proteins involved in apoptosis and epidermal growth factor receptor (EGFR)-mediated PI3K/Akt/GSK-3β signalling by immunoblotting and immunocytochemistry. The pro-apoptotic proteins (Bax, Caspase-3) were found to be up regulated and anti-apoptotic protein (Bcl-2) was down regulated on treatment with AuNPs-Qu-5. Additionally, AuNPs-Qu-5 treatment inhibited the EGFR and its downstream signalling molecules PI3K/Akt/mTOR/GSK-3β. In conclusion, administration of AuNPs-Qu-5 in breast cancer cell lines curtails cell proliferation through induction of apoptosis and also suppresses EGFR signalling. AuNPs-Qu-5 is more potent than free quercetin in causing cancer cell death, and hence, this could be a potential drug delivery system in breast cancer therapy.Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of gold nanoparticles-conjugated quercetin (AuNPs-Qu-5) in MCF-7 and MDA-MB-231 breast cancer cell lines. Borohydride reduced AuNPs were synthesized and conjugated with quercetin to yield AuNPs-Qu-5. Both were thoroughly characterized by several physicochemical techniques, and their cytotoxic effects were assessed by MTT assay. Apoptotic studies such as DAPI, AO/EtBr dual staining, and annexin V-FITC staining were performed. AuNPs and AuNPs-Qu-5 were spherical with crystalline nature, and the size of particles range from 3.0 to 4.5 nm. AuNPs-Qu-5 exhibited lower IC50 value compared to free Qu. There was a considerable increase in apoptotic population with increased nuclear condensation seen upon treatment with AuNPs-Qu-5. To delineate the molecular mechanism behind its apoptotic role, we analysed the proteins involved in apoptosis and epidermal growth factor receptor (EGFR)-mediated PI3K/Akt/GSK-3β signalling by immunoblotting and immunocytochemistry. The pro-apoptotic proteins (Bax, Caspase-3) were found to be up regulated and anti-apoptotic protein (Bcl-2) was down regulated on treatment with AuNPs-Qu-5. Additionally, AuNPs-Qu-5 treatment inhibited the EGFR and its downstream signalling molecules PI3K/Akt/mTOR/GSK-3β. In conclusion, administration of AuNPs-Qu-5 in breast cancer cell lines curtails cell proliferation through induction of apoptosis and also suppresses EGFR signalling. AuNPs-Qu-5 is more potent than free quercetin in causing cancer cell death, and hence, this could be a potential drug delivery system in breast cancer therapy. Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of gold nanoparticles–conjugated quercetin (AuNPs‐Qu‐5) in MCF‐7 and MDA‐MB‐231 breast cancer cell lines. Borohydride reduced AuNPs were synthesized and conjugated with quercetin to yield AuNPs‐Qu‐5. Both were thoroughly characterized by several physicochemical techniques, and their cytotoxic effects were assessed by MTT assay. Apoptotic studies such as DAPI, AO/EtBr dual staining, and annexin V‐FITC staining were performed. AuNPs and AuNPs‐Qu‐5 were spherical with crystalline nature, and the size of particles range from 3.0 to 4.5 nm. AuNPs‐Qu‐5 exhibited lower IC 50 value compared to free Qu. There was a considerable increase in apoptotic population with increased nuclear condensation seen upon treatment with AuNPs‐Qu‐5. To delineate the molecular mechanism behind its apoptotic role, we analysed the proteins involved in apoptosis and epidermal growth factor receptor (EGFR)–mediated PI3K/Akt/GSK‐3β signalling by immunoblotting and immunocytochemistry. The pro‐apoptotic proteins (Bax, Caspase‐3) were found to be up regulated and anti‐apoptotic protein (Bcl‐2) was down regulated on treatment with AuNPs‐Qu‐5. Additionally, AuNPs‐Qu‐5 treatment inhibited the EGFR and its downstream signalling molecules PI3K/Akt/mTOR/GSK‐3β. In conclusion, administration of AuNPs‐Qu‐5 in breast cancer cell lines curtails cell proliferation through induction of apoptosis and also suppresses EGFR signalling. AuNPs‐Qu‐5 is more potent than free quercetin in causing cancer cell death, and hence, this could be a potential drug delivery system in breast cancer therapy. Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit anticarcinogenic effects against various cancers including breast cancer. Hence, the present study was designed to evaluate the effects of gold nanoparticles–conjugated quercetin (AuNPs‐Qu‐5) in MCF‐7 and MDA‐MB‐231 breast cancer cell lines. Borohydride reduced AuNPs were synthesized and conjugated with quercetin to yield AuNPs‐Qu‐5. Both were thoroughly characterized by several physicochemical techniques, and their cytotoxic effects were assessed by MTT assay. Apoptotic studies such as DAPI, AO/EtBr dual staining, and annexin V‐FITC staining were performed. AuNPs and AuNPs‐Qu‐5 were spherical with crystalline nature, and the size of particles range from 3.0 to 4.5 nm. AuNPs‐Qu‐5 exhibited lower IC50 value compared to free Qu. There was a considerable increase in apoptotic population with increased nuclear condensation seen upon treatment with AuNPs‐Qu‐5. To delineate the molecular mechanism behind its apoptotic role, we analysed the proteins involved in apoptosis and epidermal growth factor receptor (EGFR)–mediated PI3K/Akt/GSK‐3β signalling by immunoblotting and immunocytochemistry. The pro‐apoptotic proteins (Bax, Caspase‐3) were found to be up regulated and anti‐apoptotic protein (Bcl‐2) was down regulated on treatment with AuNPs‐Qu‐5. Additionally, AuNPs‐Qu‐5 treatment inhibited the EGFR and its downstream signalling molecules PI3K/Akt/mTOR/GSK‐3β. In conclusion, administration of AuNPs‐Qu‐5 in breast cancer cell lines curtails cell proliferation through induction of apoptosis and also suppresses EGFR signalling. AuNPs‐Qu‐5 is more potent than free quercetin in causing cancer cell death, and hence, this could be a potential drug delivery system in breast cancer therapy. |
| Author | Bhat, Firdous Ahmad Arunakaran, Jagadeesan Patra, Chitta Ranjan Das, Sourav Mukherjee, Sudip Raja Singh, Paulraj Balakrishnan, Solaimuthu |
| Author_xml | – sequence: 1 givenname: Solaimuthu orcidid: 0000-0001-9920-7711 surname: Balakrishnan fullname: Balakrishnan, Solaimuthu organization: Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras – sequence: 2 givenname: Sudip surname: Mukherjee fullname: Mukherjee, Sudip organization: Training and Development Complex – sequence: 3 givenname: Sourav surname: Das fullname: Das, Sourav organization: Training and Development Complex – sequence: 4 givenname: Firdous Ahmad surname: Bhat fullname: Bhat, Firdous Ahmad organization: Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras – sequence: 5 givenname: Paulraj surname: Raja Singh fullname: Raja Singh, Paulraj organization: Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras – sequence: 6 givenname: Chitta Ranjan surname: Patra fullname: Patra, Chitta Ranjan organization: Training and Development Complex – sequence: 7 givenname: Jagadeesan orcidid: 0000-0001-7876-6899 surname: Arunakaran fullname: Arunakaran, Jagadeesan email: j_arunakaran@hotmail.com organization: Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28498520$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1uEzEUhS1URH9A4gmQJTZlMcn12DPYyzQ0oaIRCMF65LE91GFiT20PVXZ9BCQegvfqk-C0BaQKNr6W9d3je885RHvOO4PQcwITAlBOVdtNaFnXj9ABASEK4IztoQMoa1rUjLN9dBjjGgBETeEJ2i85E7wq4QD9XPpeYyedH2RIVvUm3lz_UN6txy8yGY0vRxOUSdZh6_SoTMRy8EPy0Ub8zcr8emFbm6x32Hf4dLn4OP1wRt9NZ19TFtoYbW9lBpkuruQ247gNRsaElXTKBKxM3-Peuix8vJovbq6_v8bSabx6M8v31Uk-SkpePUWPO9lH8-y-HqHPi9NP87fF-fvl2Xx2XijKRF0oRomRklW6ZFq3oLuSVS2oClhZA-14xagUnDPgNW1bEJoRQWvg3HRalB09Qsd3ukPwefWYmo2NuxmlM36MDeFCkOw5oxl9-QBd-zG4PF1DBGSjq4pApl7cU2Ob3WiGYDcybJvfEfz9UQUfYzDdH4RAs0u3yek2u3QzOnmAKpvkzvsUpO3_1VDcNVzZ3mz_K9zMTxa3_C_jOLen |
| CitedBy_id | crossref_primary_10_1039_D1RA02004H crossref_primary_10_1007_s11033_022_07616_6 crossref_primary_10_2174_1381612828666220328121211 crossref_primary_10_3390_pharmaceutics11120683 crossref_primary_10_1007_s13399_024_05600_7 crossref_primary_10_1016_j_jtemb_2023_127286 crossref_primary_10_1016_j_biopha_2025_118227 crossref_primary_10_2147_IJN_S509877 crossref_primary_10_3390_pharmaceutics16030380 crossref_primary_10_1007_s00044_023_03063_5 crossref_primary_10_3390_molecules25204613 crossref_primary_10_3389_fchem_2021_629635 crossref_primary_10_3390_pharmaceutics13071098 crossref_primary_10_1007_s12668_024_01386_0 crossref_primary_10_1016_j_bbii_2024_100088 crossref_primary_10_1016_j_ijbiomac_2023_124853 crossref_primary_10_3390_ijms21020455 crossref_primary_10_1093_jambio_lxac044 crossref_primary_10_1016_j_jddst_2024_105766 crossref_primary_10_3390_cancers14194558 crossref_primary_10_3390_molecules27144521 crossref_primary_10_3390_ijms23137400 crossref_primary_10_1007_s10555_023_10119_w crossref_primary_10_3390_cancers11050597 crossref_primary_10_3892_ol_2017_7421 crossref_primary_10_1016_j_molstruc_2021_131556 crossref_primary_10_1039_D0RA05793B crossref_primary_10_1016_j_ijbiomac_2021_03_146 crossref_primary_10_1186_s12967_024_05488_x crossref_primary_10_1007_s11051_024_05990_9 crossref_primary_10_1038_s41598_020_66419_6 crossref_primary_10_1016_j_ijpharm_2023_123486 crossref_primary_10_1159_000531802 crossref_primary_10_1016_j_semcancer_2022_02_022 crossref_primary_10_1002_mco2_163 crossref_primary_10_1002_med_21971 crossref_primary_10_1016_j_bcab_2025_103776 crossref_primary_10_1039_C9RA01041F crossref_primary_10_1002_cbf_3920 crossref_primary_10_3892_ol_2021_13015 crossref_primary_10_1016_j_biopha_2021_111847 crossref_primary_10_1080_10408398_2024_2398636 crossref_primary_10_3390_onco5020027 crossref_primary_10_1002_jcp_27628 crossref_primary_10_3390_pharmaceutics15061656 crossref_primary_10_1016_j_jbc_2023_104814 crossref_primary_10_1007_s00210_020_01874_6 crossref_primary_10_1016_j_semcancer_2019_08_029 crossref_primary_10_1039_C7RA09825A crossref_primary_10_3390_ijms22052742 crossref_primary_10_1039_C8NR09107B crossref_primary_10_1016_j_phymed_2024_155902 crossref_primary_10_1002_cbf_70006 crossref_primary_10_1002_wnan_1691 crossref_primary_10_1016_j_scitotenv_2024_170064 crossref_primary_10_1016_j_jpha_2024_100965 crossref_primary_10_1177_11782234221086728 crossref_primary_10_3390_ijms23042150 crossref_primary_10_3892_ol_2019_10767 crossref_primary_10_1016_j_arabjc_2021_103212 crossref_primary_10_1016_j_colsurfb_2024_114073 crossref_primary_10_1155_2021_5537737 crossref_primary_10_1002_adfm_201800692 crossref_primary_10_32604_biocell_2023_030742 crossref_primary_10_1007_s40097_021_00396_8 crossref_primary_10_1016_j_ijpharm_2020_119192 crossref_primary_10_1002_jcb_29147 crossref_primary_10_1002_jcb_27488 crossref_primary_10_1016_j_jddst_2022_103938 crossref_primary_10_32604_or_2024_045433 crossref_primary_10_3390_pharmaceutics14020469 crossref_primary_10_1016_j_ijbiomac_2023_128626 crossref_primary_10_3390_ijms25042360 crossref_primary_10_1039_D1FO00851J crossref_primary_10_1016_j_jddst_2022_103548 crossref_primary_10_1016_j_colsurfb_2019_02_054 crossref_primary_10_3389_fphar_2021_792777 crossref_primary_10_1016_j_jddst_2024_105609 crossref_primary_10_1016_j_procbio_2024_03_010 crossref_primary_10_3390_medicina61081347 crossref_primary_10_1080_01635581_2021_1897631 crossref_primary_10_3390_ijms231911746 crossref_primary_10_1016_j_phymed_2024_155600 crossref_primary_10_3390_molecules25153531 crossref_primary_10_1007_s11033_023_08848_w crossref_primary_10_1016_j_pmatsci_2023_101070 crossref_primary_10_1155_2018_4365739 crossref_primary_10_1002_ptr_6155 crossref_primary_10_1007_s11427_023_2499_2 crossref_primary_10_1016_j_nano_2022_102613 crossref_primary_10_1134_S0003683822090149 crossref_primary_10_2174_0929867330666230301121611 crossref_primary_10_1016_j_jddst_2022_103832 crossref_primary_10_2147_BTT_S484068 crossref_primary_10_1016_j_lfs_2021_120240 crossref_primary_10_1002_med_22107 crossref_primary_10_4103_pm_pm_223_20 crossref_primary_10_1016_j_bmc_2024_117877 crossref_primary_10_1016_j_phrs_2020_105086 crossref_primary_10_3390_molecules24234246 crossref_primary_10_1109_TNB_2020_3028562 crossref_primary_10_2174_0929867330666230303120942 crossref_primary_10_1007_s00210_023_02625_z crossref_primary_10_1007_s10787_019_00660_y crossref_primary_10_1111_1749_4877_12763 crossref_primary_10_1016_j_freeradbiomed_2018_10_429 crossref_primary_10_1002_ddr_21938 crossref_primary_10_1016_j_semcancer_2019_07_023 crossref_primary_10_1007_s11033_021_06516_5 crossref_primary_10_1016_j_lfs_2020_117481 crossref_primary_10_1080_07388551_2023_2225131 crossref_primary_10_1016_j_biopha_2020_110372 crossref_primary_10_3389_fonc_2021_664380 crossref_primary_10_3390_ijms19124100 crossref_primary_10_1039_D4NH00497C crossref_primary_10_1080_13813455_2020_1773864 crossref_primary_10_1002_adfm_201904268 crossref_primary_10_1039_C9BM00423H crossref_primary_10_3389_fmicb_2021_658294 crossref_primary_10_3390_medicina55040114 |
| Cites_doi | 10.1007/s10549-011-1601-4 10.1006/bbrc.1995.1355 10.1016/j.neuint.2014.12.001 10.1016/S0021-9258(19)52451-6 10.1039/b712170a 10.1039/C4FO00255E 10.1016/j.clnu.2003.12.004 10.1007/978-94-011-6017-9 10.1007/s00394-004-0503-1 10.1002/pros.20410 10.1177/0960327109107002 10.1002/cmdc.201100311 10.1016/j.bionut.2014.07.003 10.2174/157489210790936261 10.1016/j.jcis.2014.08.064 10.1007/s10456-010-9193-x 10.1002/jcb.10559 10.1016/j.cell.2012.03.017 10.1155/2014/150845 10.1172/JCI26252 10.1021/nn901877h 10.1016/S0092-8674(00)81334-3 10.1109/TBME.2011.2124460 10.1021/nl0483789 10.7150/thno.7819 10.1038/srep24049 10.1111/j.1742-4658.2009.07448.x 10.3892/etm.2015.2536 10.1021/ja902062j 10.1007/s00432-005-0005-4 10.1002/ijc.26440 10.1016/0022-1759(83)90303-4 10.1016/j.colsurfb.2011.10.036 10.3390/ijms15058216 10.1016/j.ejmech.2013.03.058 10.1016/j.colsurfb.2013.01.035 10.1016/j.lfs.2004.11.003 10.1021/ja908117a 10.1021/ja205684a 10.1088/0957-4484/23/5/055602 10.1016/j.pharmthera.2010.01.009 10.3892/etm.2013.1285 10.1039/c4nr00974f 10.1016/j.biomaterials.2006.12.025 10.1080/03639040601150195 10.1016/j.jconrel.2006.06.017 10.1016/j.fct.2012.01.025 10.1021/ac902492c 10.1016/j.cbi.2014.09.025 10.1080/01635581.2016.1145245 10.1016/j.colsurfb.2013.01.061 10.1038/sj.cdd.4400963 10.1038/nrm3025 10.1016/j.ejphar.2016.03.063 10.1039/b914071a 10.1039/c0dt00689k 10.1016/S0898-6568(01)00271-6 10.3892/ijmm.2016.2625 |
| ContentType | Journal Article |
| Copyright | Copyright © 2017 John Wiley & Sons, Ltd. |
| Copyright_xml | – notice: Copyright © 2017 John Wiley & Sons, Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TM 7U7 8FD C1K FR3 P64 RC3 7X8 |
| DOI | 10.1002/cbf.3266 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database Toxicology Abstracts Nucleic Acids Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Genetics Abstracts MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Biology |
| EISSN | 1099-0844 |
| EndPage | 231 |
| ExternalDocumentID | 28498520 10_1002_cbf_3266 CBF3266 |
| Genre | article Journal Article |
| GrantInformation_xml | – fundername: DST, New Delhi for the CSIR 12th Five Year Plan project (Advanced Drug Delivery System: CSC‐0302) and Nanomission project funderid: SR/NM/NS‐1252/2013; GAP0570 – fundername: CSIR, New Delhi – fundername: University of Madras for UPE Phase II fellowship |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 29B 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BLYAC BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LH6 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NDZJH NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E V8K W8V W99 WBKPD WH7 WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WXI WXSBR WYISQ XG1 XPP XV2 ZZTAW ~IA ~WT AAYXX AIQQE CITATION O8X AAHHS ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TM 7U7 8FD C1K FR3 P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c3496-c431eaa45d24ddb0df245b0c5042603f8543a98840863bb09d41936088efd92f3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 141 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000402993900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0263-6484 1099-0844 |
| IngestDate | Fri Jul 11 10:13:56 EDT 2025 Fri Jul 25 12:09:54 EDT 2025 Thu Apr 03 07:02:30 EDT 2025 Sat Nov 29 07:18:14 EST 2025 Tue Nov 18 22:31:56 EST 2025 Wed Aug 20 07:24:31 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | gold nanoparticles and quercetin apoptosis breast cancer drug delivery EGFR |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor Copyright © 2017 John Wiley & Sons, Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3496-c431eaa45d24ddb0df245b0c5042603f8543a98840863bb09d41936088efd92f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-9920-7711 0000-0001-7876-6899 |
| PMID | 28498520 |
| PQID | 1906305510 |
| PQPubID | 2029981 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_1899110043 proquest_journals_1906305510 pubmed_primary_28498520 crossref_primary_10_1002_cbf_3266 crossref_citationtrail_10_1002_cbf_3266 wiley_primary_10_1002_cbf_3266_CBF3266 |
| PublicationCentury | 2000 |
| PublicationDate | June 2017 2017-06-00 2017-Jun 20170601 |
| PublicationDateYYYYMMDD | 2017-06-01 |
| PublicationDate_xml | – month: 06 year: 2017 text: June 2017 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Bognor Regis |
| PublicationTitle | Cell biochemistry and function |
| PublicationTitleAlternate | Cell Biochem Funct |
| PublicationYear | 2017 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2002; 14 2005; 131 2013; 64 2004; 23 2004; 4 2008; 37 1975 2016; 781 2011; 56 2011; 12 2015; 80 2014; 28 2011; 58 2011; 14 2007; 33 2016; 38 2013; 6 2007; 28 2012; 131 2014; 5 2014; 4 2011; 129 2006; 66 2010; 277 1995; 208 1951; 193 1983; 65 2014; 15 2005; 76 2014; 18 2012; 25 2009; 19 2010; 5 2012; 23 2010; 4 2014; 6 2003; 89 2014; 436 1996; 18 2015; 18 2002; 9 2010; 126 2005; 115 2011; 40 2013; 107 2015; 10 2013; 106 2014; 2014 2009; 131 2016; 18 2011; 6 2012; 149 2005; 44 2011; 133 2006; 114 2010; 82 2016; 11 2009; 28 2012; 50 2004; 11 2016; 6 2012; 91 2010; 132 2016 2016; 68 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_17_1 e_1_2_7_62_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_66_1 e_1_2_7_11_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 Ong C (e_1_2_7_48_1) 2004; 11 e_1_2_7_50_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 Abdelhalim MA (e_1_2_7_32_1) 2012; 25 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 Atashpour S (e_1_2_7_45_1) 2015; 18 e_1_2_7_21_1 e_1_2_7_56_1 Mukherjee S (e_1_2_7_34_1) 2016; 11 e_1_2_7_37_1 e_1_2_7_58_1 e_1_2_7_39_1 Balakrishnan S (e_1_2_7_42_1) 2016; 18 e_1_2_7_6_1 e_1_2_7_4_1 Baran I (e_1_2_7_35_1) 2011; 56 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_61_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_63_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_65_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_67_1 e_1_2_7_27_1 e_1_2_7_29_1 Huang L (e_1_2_7_5_1) 2014; 28 e_1_2_7_51_1 e_1_2_7_30_1 e_1_2_7_53_1 e_1_2_7_24_1 e_1_2_7_55_1 e_1_2_7_22_1 e_1_2_7_57_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_38_1 39748200 - Cell Biochem Funct. 2025 Jan;43(1):e70041. doi: 10.1002/cbf.70041 |
| References_xml | – volume: 114 start-page: 343 year: 2006 end-page: 347 article-title: PEG‐modified gold nanorods with a stealth character for in vivo applications publication-title: J Control Release – volume: 37 start-page: 1896 year: 2008 end-page: 1981 article-title: Biological applications of gold nanoparticles publication-title: Chem Soc Rev – volume: 64 start-page: 99 year: 2013 end-page: 110 article-title: Design, synthesis and antiproliferative activity studies of novel 1,2,3‐triazole‐dithiocarbamate‐urea hybrids publication-title: Eur J Med Chem – volume: 781 start-page: 60 year: 2016 end-page: 68 article-title: Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer publication-title: Eur J Pharmacol – volume: 208 start-page: 425 year: 1995 end-page: 341 article-title: Quercetin down‐regulates signal transduction in human breast carcinoma cells publication-title: Biochem Biophys Res Commun – volume: 56 start-page: 388 year: 2011 end-page: 398 article-title: Tofolean. Fluorescence properties of quercetin in human leukemia Jurkat_T cells publication-title: J Phys – volume: 58 start-page: 2002 year: 2011 end-page: 2012 article-title: A radio‐frequency coupling network for heating of citrate‐coated gold nanoparticles for cancer therapy: design and analysis publication-title: IEEE Trans Biomed Eng – volume: 19 start-page: 7879 year: 2009 end-page: 7884 article-title: Doxorubicin conjugated gold nanoparticles as water‐soluble and pH‐responsive anticancer drug nanocarriers publication-title: J Mater Chem – volume: 23 start-page: 055602 year: 2012 article-title: Synthesis of iron nanoparticles from hemoglobin and myoglobin publication-title: Nanotechnology – year: 1975 – volume: 38 start-page: 619 year: 2016 end-page: 626 article-title: Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial‐dependent apoptosis through the inhibition of PI3K/Akt signaling publication-title: Int J Mol Med – volume: 44 start-page: 143 year: 2005 end-page: 156 article-title: Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer‐related mechanisms in colon cancer cells in vitro publication-title: Eur J Nutr – volume: 6 start-page: 2003 year: 2011 end-page: 2008 article-title: Encapsulation of docetaxel into PEGylated gold nanoparticles for vectorization to cancer cells publication-title: Chem Med Chem – volume: 132 start-page: 4678 year: 2010 end-page: 4684 article-title: Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin publication-title: J Am Chem Soc – volume: 4 start-page: 3689 year: 2010 end-page: 3696 article-title: A drug‐loaded aptamer‐gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer publication-title: ACS Nano – volume: 11 start-page: 1 year: 2016 end-page: 17 article-title: Green synthesis and characterization of monodispersed gold nanoparticles: toxicity study, delivery of doxorubicin and its bio‐distribution in mouse model publication-title: J Biomed Nanotechnol – volume: 82 start-page: 1151 year: 2010 end-page: 1156 article-title: Enhanced gold nanoparticle based ELISA for a breast cancer biomarker publication-title: Anal Chem – volume: 18 start-page: 78 year: 2014 end-page: 88 article-title: Synthesis and characterisation of morin reduced gold nanoparticles and its cytotoxicity in MCF‐7 cells publication-title: Chem Biol Interact – volume: 131 start-page: 813 year: 2012 end-page: 820 article-title: Oncogenic PIK3CA mutations in colorectal cancers and polyps publication-title: Int J Cancer – volume: 68 start-page: 250 year: 2016 end-page: 266 article-title: New approach for treatment of primary liver tumors: the role of quercetin publication-title: Nutr Cancer – volume: 436 start-page: 234 year: 2014 end-page: 242 article-title: Quercetin conjugated superparamagnetic magnetite nanoparticles for in‐vitro analysis of breast cancer cell lines for chemotherapy applications publication-title: J Colloid Interface Sci – volume: 5 start-page: 152 year: 2010 end-page: 164 article-title: Flavonoids: recent advances as anticancer drugs publication-title: Recent Pat Anticancer Drug Discov – volume: 4 start-page: 459 year: 2014 end-page: 468 article-title: Epidermal growth factor‐induced prostate cancer (PC3) cell survival and proliferation is inhibited by quercetin, a plant flavonoid through apoptotic machinery publication-title: Biomed Prev Nutr – volume: 23 start-page: 721 year: 2004 end-page: 732 article-title: Comparative toxicity of oleic acid and linoleic acid on Jurkat cells publication-title: Clin Nutr – volume: 25 start-page: 10 year: 2012 end-page: 15 article-title: Physical properties of different gold nanoparticles: ultraviolet‐visible and fluorescence measurements publication-title: J Nanomed Nanotechol – volume: 193 start-page: 265 year: 1951 end-page: 275 article-title: Protein measurement with the Folin phenol reagent publication-title: J Biol Chem – volume: 2014 start-page: 150845 year: 2014 article-title: Apoptosis and molecular targeting therapy in cancer publication-title: Biomed Res Int – volume: 28 start-page: 14 year: 2014 end-page: 141 article-title: Phospho‐aspirin (MDC‐22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress publication-title: BMC Cancer – volume: 15 start-page: 8216 year: 2014 end-page: 8234 article-title: Efficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan publication-title: Int J Mol Sci – volume: 131 start-page: 13639 year: 2009 end-page: 13645 article-title: pH‐induced aggregation of gold nanoparticles for photothermal cancer therapy publication-title: J Am Chem Soc – volume: 89 start-page: 1044 year: 2003 end-page: 1055 article-title: Differential apoptosis‐inducing effect of quercetin and its glycosides in human promyeloleukemic HL‐60 cells by alternative activation of the caspase 3 cascade publication-title: J Cell Biochem – volume: 76 start-page: 1883 year: 2005 end-page: 1893 article-title: Increase of Bax/ Bcl‐XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line publication-title: Life Sci – volume: 10 start-page: 579 year: 2015 end-page: 583 article-title: Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV‐3 in vitro publication-title: Exp Ther Med – volume: 6 start-page: 1155 year: 2013 end-page: 1158 article-title: Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro publication-title: Exp Ther Med – volume: 9 start-page: 3 year: 2002 end-page: 5 article-title: Caspases: opening the boxes and interpreting the arrows publication-title: Cell Death Differ – volume: 6 start-page: 6745 year: 2014 end-page: 6754 article-title: Cell‐selective promoter recognition accompanies antitumor effect by glucocorticoid receptor‐targeted gold nanoparticle publication-title: Nanoscale – volume: 28 start-page: 493 year: 2009 end-page: 503 article-title: Quercetin‐induced apoptosis acts through mitochondrial‐ and caspase‐3‐dependent pathways in human breast cancer MDA‐MB‐231 cells publication-title: Hum Exp Toxicol – volume: 40 start-page: 6315 year: 2011 end-page: 6343 article-title: Synthesis and bio‐functionalization of magnetic nanoparticles for medical diagnosis and treatment publication-title: Dalton Trans – volume: 4 start-page: 2479 year: 2004 end-page: 2481 article-title: Gold nanoparticles inhibit VEGF165‐induced proliferation of HUVEC cells publication-title: Nano Lett – volume: 18 start-page: 171 year: 1996 article-title: Human ICE/CED‐3 protease nomenclature publication-title: Cell – volume: 11 start-page: 727 year: 2004 end-page: 733 article-title: Quercetin‐induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in bad and hypophosphorylated retinoblastoma expressions publication-title: Oncol Rep – volume: 129 start-page: 635 year: 2011 end-page: 643 article-title: PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression publication-title: Breast Cancer Res Treat – volume: 149 start-page: 274 year: 2012 end-page: 293 article-title: mTOR signaling in growth control and disease publication-title: Cell – volume: 106 start-page: 208 year: 2013 end-page: 216 article-title: Spontaneous ultrafast synthesis of gold nanoparticles using for cancer targeted drug delivery publication-title: Colloids Surf B Biointerfaces – volume: 115 start-page: 2665 year: 2005 end-page: 2672 article-title: Caspases: pharmacological manipulation of cell death publication-title: J Clin Invest – volume: 18 start-page: 635 year: 2015 end-page: 643 article-title: Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin publication-title: Iran J Basic Med Sci – volume: 12 start-page: 21 year: 2011 end-page: 35 article-title: mTOR: from growth signal integration to cancer, diabetes and ageing publication-title: Nat Rev Mol Cell Biol – volume: 28 start-page: 2147 year: 2007 end-page: 2154 article-title: A piezoelectric immunosensor for the detection of alpha‐fetoprotein using an interface of gold/hydroxyapatite hybrid nanomaterial publication-title: Biomaterials – year: 2016 – volume: 91 start-page: 68 year: 2012 end-page: 76 article-title: A double‐targeted magnetic nanocarrier with potential application in hydrophobic drug delivery publication-title: Colloids Surf B Biointerfaces – volume: 65 start-page: 55 year: 1983 end-page: 63 article-title: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays publication-title: J Immunol Methods – volume: 33 start-page: 245 year: 2007 end-page: 253 article-title: Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes publication-title: Drug Dev Ind Pharm – volume: 5 start-page: 2632 year: 2014 end-page: 2645 article-title: Quercetin, a natural dietary flavonoid, acts as a chemopreventive agent against prostate cancer in an in vivo model by inhibiting the EGFR signaling pathway publication-title: Food Funct – volume: 50 start-page: 1589 year: 2012 end-page: 1599 article-title: Antitumor activities of quercetin and quercetin‐5',8‐disulfonate in human colon and breast cancer cell lines publication-title: Food Chem Toxicol – volume: 80 start-page: 60 year: 2015 end-page: 71 article-title: Quercetin promotes cell apoptosis and inhibits the expression of MMP‐9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells publication-title: Neurochem Int – volume: 66 start-page: 1203 year: 2006 end-page: 1212 article-title: Expression of mTOR signaling pathway markers in prostate cancer progression publication-title: Prostate – volume: 277 start-page: 301 year: 2010 end-page: 308 article-title: Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer publication-title: FEBS J – volume: 126 start-page: 9 year: 2010 end-page: 20 article-title: Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes publication-title: Pharmacol Ther – volume: 133 start-page: 13886 year: 2011 end-page: 13899 article-title: Determination of molecular configuration by debye length modulation publication-title: J Am Chem Soc – volume: 107 start-page: 27 year: 2013 end-page: 34 article-title: One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis publication-title: Colloids Surf B Biointerfaces – volume: 14 start-page: 381 year: 2002 end-page: 395 article-title: The protein kinase B/Akt signalling pathway in human malignancy publication-title: Cell Signal – volume: 18 year: 2016 article-title: Gold nanoparticle‐conjugated quercetin inhibits epithelial‐mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR‐2‐mediated pathway in breast cancer publication-title: Cell Prolif – volume: 131 start-page: 765 year: 2005 end-page: 771 article-title: Quercetin‐induced growth inhibition and cell death in prostatic carcinoma cells (PC‐3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression publication-title: J Cancer Res Clin Oncol – volume: 14 start-page: 29 year: 2011 end-page: 45 article-title: Gold nanoparticles inhibit vascular endothelial growth factor‐induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells publication-title: Angiogenesis – volume: 4 start-page: 316 year: 2014 end-page: 335 article-title: Potential theranostics application of bio‐synthesized silver nanoparticles (4‐in‐1 system) publication-title: Theranostics – volume: 6 start-page: 24049 year: 2016 article-title: Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis publication-title: Sci Rep – ident: e_1_2_7_63_1 doi: 10.1007/s10549-011-1601-4 – ident: e_1_2_7_47_1 doi: 10.1006/bbrc.1995.1355 – ident: e_1_2_7_62_1 doi: 10.1016/j.neuint.2014.12.001 – ident: e_1_2_7_31_1 doi: 10.1016/S0021-9258(19)52451-6 – ident: e_1_2_7_8_1 doi: 10.1039/b712170a – ident: e_1_2_7_60_1 doi: 10.1039/C4FO00255E – ident: e_1_2_7_30_1 doi: 10.1016/j.clnu.2003.12.004 – ident: e_1_2_7_36_1 doi: 10.1007/978-94-011-6017-9 – volume: 25 start-page: 10 year: 2012 ident: e_1_2_7_32_1 article-title: Physical properties of different gold nanoparticles: ultraviolet‐visible and fluorescence measurements publication-title: J Nanomed Nanotechol – ident: e_1_2_7_49_1 doi: 10.1007/s00394-004-0503-1 – ident: e_1_2_7_67_1 doi: 10.1002/pros.20410 – ident: e_1_2_7_57_1 doi: 10.1177/0960327109107002 – ident: e_1_2_7_41_1 doi: 10.1002/cmdc.201100311 – ident: e_1_2_7_44_1 doi: 10.1016/j.bionut.2014.07.003 – ident: e_1_2_7_14_1 doi: 10.2174/157489210790936261 – volume: 11 start-page: 727 year: 2004 ident: e_1_2_7_48_1 article-title: Quercetin‐induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in bad and hypophosphorylated retinoblastoma expressions publication-title: Oncol Rep – ident: e_1_2_7_40_1 doi: 10.1016/j.jcis.2014.08.064 – ident: e_1_2_7_20_1 doi: 10.1007/s10456-010-9193-x – ident: e_1_2_7_46_1 doi: 10.1002/jcb.10559 – ident: e_1_2_7_66_1 doi: 10.1016/j.cell.2012.03.017 – ident: e_1_2_7_43_1 doi: 10.1155/2014/150845 – ident: e_1_2_7_55_1 doi: 10.1172/JCI26252 – ident: e_1_2_7_2_1 – ident: e_1_2_7_26_1 doi: 10.1021/nn901877h – ident: e_1_2_7_56_1 doi: 10.1016/S0092-8674(00)81334-3 – ident: e_1_2_7_19_1 doi: 10.1109/TBME.2011.2124460 – ident: e_1_2_7_25_1 doi: 10.1021/nl0483789 – ident: e_1_2_7_27_1 doi: 10.7150/thno.7819 – ident: e_1_2_7_58_1 doi: 10.1038/srep24049 – ident: e_1_2_7_4_1 doi: 10.1111/j.1742-4658.2009.07448.x – volume: 28 start-page: 14 year: 2014 ident: e_1_2_7_5_1 article-title: Phospho‐aspirin (MDC‐22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress publication-title: BMC Cancer – ident: e_1_2_7_10_1 doi: 10.3892/etm.2015.2536 – ident: e_1_2_7_18_1 doi: 10.1021/ja902062j – ident: e_1_2_7_51_1 doi: 10.1007/s00432-005-0005-4 – ident: e_1_2_7_64_1 doi: 10.1002/ijc.26440 – ident: e_1_2_7_29_1 doi: 10.1016/0022-1759(83)90303-4 – volume: 11 start-page: 1 year: 2016 ident: e_1_2_7_34_1 article-title: Green synthesis and characterization of monodispersed gold nanoparticles: toxicity study, delivery of doxorubicin and its bio‐distribution in mouse model publication-title: J Biomed Nanotechnol – ident: e_1_2_7_17_1 doi: 10.1016/j.colsurfb.2011.10.036 – ident: e_1_2_7_38_1 doi: 10.3390/ijms15058216 – ident: e_1_2_7_9_1 doi: 10.1016/j.ejmech.2013.03.058 – ident: e_1_2_7_23_1 doi: 10.1016/j.colsurfb.2013.01.035 – ident: e_1_2_7_50_1 doi: 10.1016/j.lfs.2004.11.003 – ident: e_1_2_7_22_1 doi: 10.1021/ja908117a – ident: e_1_2_7_15_1 doi: 10.1021/ja205684a – ident: e_1_2_7_16_1 doi: 10.1088/0957-4484/23/5/055602 – volume: 56 start-page: 388 year: 2011 ident: e_1_2_7_35_1 article-title: Tofolean. Fluorescence properties of quercetin in human leukemia Jurkat_T cells publication-title: J Phys – ident: e_1_2_7_13_1 doi: 10.1016/j.pharmthera.2010.01.009 – ident: e_1_2_7_53_1 doi: 10.3892/etm.2013.1285 – ident: e_1_2_7_33_1 doi: 10.1039/c4nr00974f – ident: e_1_2_7_7_1 doi: 10.1016/j.biomaterials.2006.12.025 – ident: e_1_2_7_37_1 doi: 10.1080/03639040601150195 – ident: e_1_2_7_24_1 doi: 10.1016/j.jconrel.2006.06.017 – ident: e_1_2_7_52_1 doi: 10.1016/j.fct.2012.01.025 – ident: e_1_2_7_21_1 doi: 10.1021/ac902492c – ident: e_1_2_7_3_1 doi: 10.1016/j.cbi.2014.09.025 – ident: e_1_2_7_12_1 doi: 10.1080/01635581.2016.1145245 – ident: e_1_2_7_28_1 doi: 10.1016/j.colsurfb.2013.01.061 – volume: 18 start-page: 635 year: 2015 ident: e_1_2_7_45_1 article-title: Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin publication-title: Iran J Basic Med Sci – ident: e_1_2_7_54_1 doi: 10.1038/sj.cdd.4400963 – ident: e_1_2_7_65_1 doi: 10.1038/nrm3025 – ident: e_1_2_7_11_1 doi: 10.1016/j.ejphar.2016.03.063 – ident: e_1_2_7_39_1 doi: 10.1039/b914071a – volume: 18 year: 2016 ident: e_1_2_7_42_1 article-title: Gold nanoparticle‐conjugated quercetin inhibits epithelial‐mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR‐2‐mediated pathway in breast cancer publication-title: Cell Prolif – ident: e_1_2_7_6_1 doi: 10.1039/c0dt00689k – ident: e_1_2_7_59_1 doi: 10.1016/S0898-6568(01)00271-6 – ident: e_1_2_7_61_1 doi: 10.3892/ijmm.2016.2625 – reference: 39748200 - Cell Biochem Funct. 2025 Jan;43(1):e70041. doi: 10.1002/cbf.70041 |
| SSID | ssj0009630 |
| Score | 2.5113847 |
| Snippet | Epidermal growth factor plays a major role in breast cancer cell proliferation, survival, and metastasis. Quercetin, a bioactive flavonoid, is shown to exhibit... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 217 |
| SubjectTerms | 1-Phosphatidylinositol 3-kinase AKT protein Annexin V Apoptosis Apoptosis - drug effects Assaying BAX protein Bcl-2 protein Biocompatibility Biomedical materials Biotechnology Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer Caspase Caspase-3 Cell death Cell growth Cell proliferation Cell survival Condensation Crystal structure Cytotoxicity Drug delivery Drug delivery systems Drug Delivery Systems - methods EGFR Epidermal growth factor Epidermal growth factor receptors Female Glycogen Synthase Kinase 3 beta - metabolism Gold Gold - chemistry gold nanoparticles and quercetin Humans Immunoblotting Immunocytochemistry MAP Kinase Signaling System - drug effects MCF-7 Cells Metal Nanoparticles Metastases Nanoparticles Phosphatidylinositol 3-Kinases - metabolism Proteins Proto-Oncogene Proteins c-akt - metabolism Quercetin - chemistry Quercetin - pharmacology Signal transduction Signaling Staining Surgical implants Survival Therapy TOR Serine-Threonine Kinases - metabolism Tumor cell lines |
| Title | Gold nanoparticles–conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt–mediated pathway in breast cancer cell lines (MCF‐7 and MDA‐MB‐231) |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbf.3266 https://www.ncbi.nlm.nih.gov/pubmed/28498520 https://www.proquest.com/docview/1906305510 https://www.proquest.com/docview/1899110043 |
| Volume | 35 |
| WOSCitedRecordID | wos000402993900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1099-0844 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009630 issn: 0263-6484 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZYBxovXAaDwpiMhLg8hKaxnTiPXbcMBJ2miUl9i3wVhSmpmnRob_sJSPwI_td-CcdO0mkCJCRekig5viQ-tr_jHH8HoRdGDRMYAmSgQgUGiuLDgKdcBjSmFmZ4y2KqfLCJ5PCQT6fpUetV6fbCNPwQqwU31zP8eO06uJDV4Io0VEn7FrBHvIbWI1Bb2kPre8fZyccryt2YtCssJIgppx31bBgNurTXJ6PfEOZ1wOpnnOzu_9T1HrrT4kw8ahTjPrphik10q4k8eb6JNsZdoLcH6OdBeapxIQqwn1s3ucuLH2Anf1m6NTaNoboL5bZGYzDgQRUqLOblvC6rWYXPZgLufp5J7_qFS4v3D7LjwdF78mEw-lpDRn5visvGBT_-Js5BHEvnCl9j5VRugd3PA-xessKvJ-Ps8uJ7gkWh8WRvBNeTXTgAPnzzEJ1k-5_G74I2fkOgHA19oACcGCEo0xHVWobaRpTJUDFPi08sZ5SIlIOJyWMiZZhqCnAyhnHPWJ1GlmyhXlEW5jHCTFmhhSFMSEtZanhsFBGAJakkIklZH73qGjJXLbm5i7Fxmje0zFEOTZC7Juij5yvJeUPo8QeZ7U4X8rZLVzkgp9jRow1DyGL1GJrKfSRRmHIJMmC9eg4-0kePGh1aFQI4IOUsgtQvvar8tfR8vJu585N_FXyKbkcObPi1oW3UqxdL8wzdVGf1rFrsoLVkynfazvELEqEUww |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD4aHWi8cBm3wgAjIRgPoWlsp4546rplm9ZW07RJe4t8iyhMSdW0Q3vbT0DiR_C_9ks4zqXTBEhIvCRRcnxJfGx_58T-DsBbq7s9HAKUp32NBooWXU9EQnksZCnO8CkPmS6DTfTGY3F6Gh2uwKdmL0zFD7F0uLmeUY7XroM7h3TnmjVUq_Qjgo_wFqwy1CLegtXto_hkeM25G9LaxUK9kAnWcM_6QadJe3M2-g1i3kSs5ZQT3_-vyj6AezXSJP1KNR7Cis3W4U4Ve_JiHdYGTai3R_BzNz8zJJMZWtD1Qrmryx9oKX9ZOC-bIVjfmXabowma8KgMBZHTfDrPi0lBzicS736eqHLxF8lTsrMbH3UO9-lBp_91jhmVu1NcNi788Td5geJEucXwc6Kd0s2I-31A3FsWZHM0iK8uv_eIzAwZbffxerSFB0SIHx7DSbxzPNjz6ggOnnZE9J5GeGKlZNwEzBjlmzRgXPmal8T4NBWcURkJNDJFSJXyI8MQUIY48tnUREFKn0AryzP7DAjXqTTSUi5VynhkRWg1lYgmmaKyF_E2vG9aMtE1vbmLsnGWVMTMQYJNkLgmaMObpeS0ovT4g8xGowxJ3amLBLFT6AjSuj5msXyMTeU-ksxsvkAZtF9LFj7ahqeVEi0LQSQQCR5g6nelrvy19GSwFbvz838VfA1re8ejYTLcHx-8gLuBgx6lp2gDWvPZwr6E2_p8Pilmr-o-8gsKihfL |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3bbtNAEF2VFgovXEqBQIFFQlweTBzvJWvxlCZ1qdpEUdVKfbP2KgKVHcVJUd_6CUh8BP_VL2HWl1QVICHxYlv2eNf2zOyeWe-eQei11Z0uNAEq0KGGAEWLTiBioQLKqYMe3jFOdZlsojsaiZOTeLyCPjZrYSp-iOWAm_eMsr32Dm6nxrWvWEO1ch8AfPAbaI2ymINXrg0Ok-ODK85dTuohFhJwKmjDPRtG7ebe673RbxDzOmItu5zk3n897H10t0aauFeZxgO0YrMNdKvKPXm-gW73m1RvD9HP3fzU4ExmEEHXE-UuL35ApPxl4UfZDIbnnWm_OBpDCA_GUGA5zafzvJgU-Gwi4ezniSonf-Hc4Z3d5LA93iP77d7XORRUrk7xxfj0x9_kOYhj5SfDz7H2RjfD_vcB9m9Z4HfDfnJ58b2LZWbwcNCD4-E2bAAhvt9Ex8nOUf9TUGdwCLQnog80wBMrJWUmosao0LiIMhVqVhLjEycYJTIWEGQKTpQKY0MBUHJo-awzceTII7Sa5Zl9gjDTThppCZPKgbqt4FYTCWiSKiK7MWuht40mU13Tm_ssG6dpRcwcpaCC1KughV4tJacVpccfZLYaY0hrpy5SwE7cE6R1QihieRlU5T-SzGy-ABmIX0sWPtJCjysjWlYCSCAWLIK735S28tfa0_524vdP_1XwJVofD5L0YG-0_wzdiTzyKAeKttDqfLawz9FNfTafFLMXtYv8AnR9F0Y |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gold+nanoparticles-conjugated+quercetin+induces+apoptosis+via+inhibition+of+EGFR%2FPI3K%2FAkt-mediated+pathway+in+breast+cancer+cell+lines+%28MCF-7+and+MDA-MB-231%29&rft.jtitle=Cell+biochemistry+and+function&rft.au=Balakrishnan%2C+Solaimuthu&rft.au=Mukherjee%2C+Sudip&rft.au=Das%2C+Sourav&rft.au=Bhat%2C+Firdous+Ahmad&rft.date=2017-06-01&rft.eissn=1099-0844&rft.volume=35&rft.issue=4&rft.spage=217&rft_id=info:doi/10.1002%2Fcbf.3266&rft_id=info%3Apmid%2F28498520&rft.externalDocID=28498520 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0263-6484&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0263-6484&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0263-6484&client=summon |